Li C, Hao M, Fang Z, Ding J, et al. PARP inhibitor plus chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: a systematic review and meta-analysis based on randomized controlled trials. Cancer Chemother Pharmacol 2023 Feb 2. doi: 10.1007/s00280-023-04506.
PMID: 36725727